[[bis[(9,10-dihydro-9,10-dioxo-1-anthryl)amino]-8,16-dihydro-8,16-dioxopyranthrenediyl]diimino]bisviolanthrone (85711-83-7)
Identification |
Properties |
Safety Data |
|
|
Other Product
- (2alpha,3alpha,3'alpha,4alpha,5beta,19beta)-10',16'-didehydro-9',10'-dihydro-3',9'-cyclovincaleukoblastine
- 1/C11H9N5O/c1-17-6-2-3-8-9(4-6)16-11(14-8)7(5-12)10(13)15-16/h2-4,14H,1H3,(H2,13,15
- 1/C13H15NO2/c15-8-10-7-9-3-1-5-14-6-2-4-11(12(9)14)13(10)16/h7-8,16H,1-6H
- 1/C14H9Br2O2P/c15-11-6-8-13(17-11)19(10-4-2-1-3-5-10)14-9-7-12(16)18-14/h1-9
- 1/C13H9IO2/c15-13-11-8-4-5-9-12(11)14(16-13)10-6-2-1-3-7-10/h1-9
- 1/C15H13NO/c1-2-16-14-6-4-3-5-12(14)13-9-11(10-17)7-8-15(13)16/h3-10H,2H2,1H
- 2-[(8'R,9'S,10'S,13'S,14'S)-13'-methyl-1',2',4',7',8',9',11',12',13',14',15',16'-dodecahydro-10'H-dispiro[1,3-dioxolane-2,17'-cyclopenta[a]phenanthrene-3',2''-[1,3]dioxolan]-10'-yl]ethanamine acetate (1:1)
- 1/C12H10N4O3/c1-3-19-12(18)10-9(7(2)17)6-14-11-8(4-13)5-15-16(10)11/h5-6H,3H2,1-2H
- 1/C13H19NO2/c1-9(15)6-7-10-8-13(16-14-10)11-4-2-3-5-12(11)13/h11-12H,2-8H2,1H
- 1/C14H16O4/c1-5-10-12-9(14(15)18-10)6-7-11(16-4)13(12)17-8(2)3/h5-8,10H,1H2,2-4H
- Propanedioic acid,(9-chloro-1,4-dihydro-10-hydroxy-8-nitro-1,4-dioxo-2-anthracenyl)-,diethyl ester
- Decanoic acid,10,10'-[(9,10-dihydro-9-oxo-4,5-acridinediyl)diimino]bis[10-oxo-
- 1/C10H13N3O3/c1-10(2,3)11-9-6-7(13(15)16)4-5-8(9)12-14/h4-6,11H,1-3H
- 9, 10-Dioxo-9, 10-Dihydroanthracene-1, 4, 5, 8-Tetracarboxylic Acid
- 1/C8H11NO7S/c1-17(13,14)5-4-15-8(12)16-9-6(10)2-3-7(9)11/h2-5H2,1H
- 1/C15H22O3/c1-9-10(2)14-12(11(3)13(9)17)5-6-15(4,18-14)7-8-16/h16-17H,5-8H2,1-4H
- 1/C11H14N2O6/c1-17-7(14)4-12-2-3-13-9(10(12)15)8-6(19-13)5-18-11(8)16/h6,8-9H,2-5H2,1H
- 5-Quinolinol,8-(9,10-dihydro-10-methyl-9-acridinyl)-
- 1,5-bis[[4-[(9,10-dihydro-9,10-dioxo-1-anthryl)amino]-9,10-dihydro-9,10-dioxo-1-anthryl]amino]anthraquinone
- 1/C14H12NS/c1-2-6-12(7-3-1)10-15-11-16-14-9-5-4-8-13(14)15/h1-9,11H,10H2/q+